Wearable Health Solutions Stock Current Valuation
| WHSI Stock | USD 0.0001 0.00 0.00% |
Valuation analysis of Wearable Health Solutions helps investors to measure Wearable Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Wearable Health's price fluctuation is very steady at this time. Calculation of the real value of Wearable Health Solutions is based on 3 months time horizon. Increasing Wearable Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Wearable Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Wearable Pink Sheet. However, Wearable Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Wearable Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Wearable Health's stock price.
Estimating the potential upside or downside of Wearable Health Solutions helps investors to forecast how Wearable pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Wearable Health more accurately as focusing exclusively on Wearable Health's fundamentals will not take into account other important factors: Wearable Health Solutions Company Current Valuation Analysis
Wearable Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Wearable Health Current Valuation | 9.9 M |
Most of Wearable Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Wearable Health Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Wearable Health Solutions has a Current Valuation of 9.9 M. This is 99.93% lower than that of the Healthcare sector and 99.89% lower than that of the Medical Instruments & Supplies industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
Wearable Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Wearable Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Wearable Health could also be used in its relative valuation, which is a method of valuing Wearable Health by comparing valuation metrics of similar companies.Wearable Health is rated fourth in current valuation category among its peers.
Wearable Fundamentals
| Return On Asset | -5.3 | |||
| Operating Margin | (10.12) % | |||
| Current Valuation | 9.9 M | |||
| Shares Outstanding | 1.53 B | |||
| Shares Owned By Insiders | 66.89 % | |||
| Price To Earning | 1.13 X | |||
| Price To Sales | 6.39 X | |||
| Revenue | 1.05 M | |||
| Gross Profit | 477.48 K | |||
| EBITDA | (12.96 M) | |||
| Net Income | (13.05 M) | |||
| Cash And Equivalents | 70.5 K | |||
| Total Debt | 1.7 M | |||
| Current Ratio | 0.12 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (3.11 M) | |||
| Earnings Per Share | 0.01 X | |||
| Target Price | 0.2 | |||
| Number Of Employees | 11 | |||
| Beta | 7.58 | |||
| Market Capitalization | 9.8 M | |||
| Total Asset | 339.06 K | |||
| Retained Earnings | (14.2 M) | |||
| Working Capital | (772 K) | |||
| Current Asset | 521 K | |||
| Current Liabilities | 1.29 M | |||
| Net Asset | 339.06 K |
About Wearable Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Wearable Health Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Wearable Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Wearable Health Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Wearable Pink Sheet
Wearable Health financial ratios help investors to determine whether Wearable Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wearable with respect to the benefits of owning Wearable Health security.